Luxdegalutamide (JSB462)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Luxdegalutamide (JSB462), covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) [Phase 2]